Quanterix Corporation (QTRX) News
Track canonical SquawkNews coverage tagged to QTRX, Quanterix Corporation. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026
Quanterix Corporation (NASDAQ: QTRX) today reported significant progress on the Content Innovation Engine it introduced at the American Association for Cancer Research (AACR) Annual Meeting 2026, highlighting new updates
NEWS | Sep 25, 2026, 12:00 PM UTC
L
QTRX - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
QTRX - Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEWS | Sep 17, 2026, 01:03 AM UTC
L
Quanterix Lowers FY2026 Sales Guidance from $169.000M-$174.000M to $142.000M-$148.000M vs $169.930M Est
Quanterix (NASDAQ: QTRX ) lowers FY2026 sales outlook from $169.000 million-$174.000 million to $142.000 million-$148.000 million vs $169.930 million estimate.
EARNINGS | Aug 10, 2026, 12:00 PM UTC
L
Anthem Blue Cross, Blue Shield establish commercial coverage for LucentAD
Anthem Blue Cross, Blue Shield establish commercial coverage for LucentAD
EQUITY | Jul 14, 2026, 08:36 PM UTC